In a recent transcriptomic study of 10 iCC cases, which revealed the variability among T cell populations within TME, CD8+ TILs from highly heterogeneous tumors exerted decreased cytotoxic capacity [64]. This evidence concerns the gene CD8A and intrahepatic cholangiocarcinoma.